In our study, focusing on never smoker patients with adenocarcinoma histology, we found no significant differences in the frequency of EGFR mutation, KRAS mutation or ALK translocation between patients < 45 years and patients ≥ 45 years. This evidence concerns the gene ALK and adenocarcinoma.